Similarities between Index of oncology articles and Pipendoxifene
Index of oncology articles and Pipendoxifene have 4 things in common (in Unionpedia): Clinical trial, Oophorectomy, Raloxifene, Selective estrogen receptor modulator.
Clinical trial
Clinical trials are experiments or observations done in clinical research.
Clinical trial and Index of oncology articles · Clinical trial and Pipendoxifene ·
Oophorectomy
Oophorectomy (from Greek ᾠοφόρος, ōophóros, 'egg-bearing' + ἐκτομή, ektomḗ, 'a cutting out of') is the surgical removal of an ovary or ovaries.
Index of oncology articles and Oophorectomy · Oophorectomy and Pipendoxifene ·
Raloxifene
Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.
Index of oncology articles and Raloxifene · Pipendoxifene and Raloxifene ·
Selective estrogen receptor modulator
Selective estrogen receptor modulators (SERMs) are a class of drugs that act on the estrogen receptor (ER).
Index of oncology articles and Selective estrogen receptor modulator · Pipendoxifene and Selective estrogen receptor modulator ·
The list above answers the following questions
- What Index of oncology articles and Pipendoxifene have in common
- What are the similarities between Index of oncology articles and Pipendoxifene
Index of oncology articles and Pipendoxifene Comparison
Index of oncology articles has 1711 relations, while Pipendoxifene has 13. As they have in common 4, the Jaccard index is 0.23% = 4 / (1711 + 13).
References
This article shows the relationship between Index of oncology articles and Pipendoxifene. To access each article from which the information was extracted, please visit: